Published in Invest Urol on May 01, 1973
Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinemia, cellular immune deficiency, and chronic lymphatic leukemia. J Clin Invest (1971) 4.98
Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. CA Cancer J Clin (1972) 3.35
Which cyclosporin formulation? Lancet (1996) 3.34
Consensus statement on the live organ donor. JAMA (2000) 3.29
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation (1996) 2.24
The influence of dosage regimen on experimental gentamicin nephrotoxicity: dissociation of peak serum levels from renal failure. J Infect Dis (1979) 1.83
Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol (1986) 1.70
Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis (2000) 1.68
Cyst decompression surgery for autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1992) 1.68
DTT test: a new method to differentiate IgM and IgG erythrocyte antibodies. Vox Sang (1974) 1.59
Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther (1975) 1.59
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
Immune haemolytic disease: the autoimmune haemolytic anaemias. Clin Haematol (1975) 1.56
IgD: a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphatic leukemia. J Immunol (1974) 1.56
Suppression of postoperative pain by preoperative administration of ibuprofen in comparison to placebo, acetaminophen, and acetaminophen plus codeine. J Clin Pharmacol (1983) 1.55
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Validity and reliability testing of the Prenatal Psychosocial Profile. Res Nurs Health (1994) 1.48
Renal manifestations of sarcoidosis. Arch Intern Med (1981) 1.47
Acute renal failure from ticrynafen. N Engl J Med (1979) 1.40
Color Doppler sonography in the evaluation of the adult acute scrotum. J Ultrasound Med (1992) 1.38
The influence of tobramycin dosage regimens on nephrotoxicity, ototoxicity, and antibacterial efficacy in a rat model of subcutaneous abscess. J Infect Dis (1988) 1.36
Intravenous immunoglobulin therapy for antibody deficiency. Clin Exp Immunol (1979) 1.36
Action and toxicity of cyclosporine. Annu Rev Med (1986) 1.35
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies. Curr Opin Crit Care (2001) 1.32
Dipstick chemical urinalysis: an accurate cost-effective screening test. J Urol (1984) 1.30
The prognostic and therapeutic implications of DNA:anti-DNA immune complexes in systemic lupus erythematosus (SLE). Am J Med (1975) 1.30
Lead nephropathy. Kidney Int (1985) 1.24
The nephropathy of the nail-patella syndrome. Clinicopathologic analysis of 11 kindred. Am J Med (1973) 1.20
Systematics of the Eucestoda: advances toward a new phylogenetic paradigm, and observations on the early diversification of tapeworms and vertebrates. Syst Parasitol (1999) 1.17
Turnover of proteoglycans in cultures of bovine articular cartilage. Arch Biochem Biophys (1984) 1.17
Cyclophosphamide and malignancy. Lancet (1977) 1.15
The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. J Thromb Haemost (2011) 1.15
Quantitative bacteriology of sputum. Am Rev Respir Dis (1968) 1.14
Digital ischemia and gangrene preceding renal neoplasm. An association with sarcomatoid adenocarcinoma of the kidney. Arch Intern Med (1976) 1.14
Drug prescribing in renal failure: dosing guidelines for adults. Am J Kidney Dis (1983) 1.13
Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. Clin Pharmacol Ther (1988) 1.12
Endogenous creatinine clearance as a clinical measure of glomerular filtration rate. Br Med J (1971) 1.12
Individual patient variations in the kinetics of intravenous immune globulin administration. J Clin Immunol (1982) 1.10
Guidelines for drug therapy in renal failure. Ann Intern Med (1977) 1.10
Drug-related syndromes in clinical nephrology. Ann Intern Med (1977) 1.10
Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol (1978) 1.10
Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med (1974) 1.10
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol (1995) 1.09
Nephrotoxic acute renal failure due to common drugs. Am J Physiol (1981) 1.09
Retrograde method for percutaneous access to kidney. Urology (1983) 1.09
Degeneria halosauri (Bell 1887) gen. et comb. n. (Digenea: Gorgoderidae) from the deep-sea telost Halosauropsis macrochir. J Parasitol (1977) 1.08
Renal function 27 years after unilateral nephrectomy for related donor kidney transplantation. J Urol (1988) 1.08
Attenuation of experimental tobramycin nephrotoxicity by ticarcillin. Antimicrob Agents Chemother (1985) 1.08
Cyclosporine nephrotoxicity. Ann Intern Med (1983) 1.07
Renal cholesterol accumulation: a durable response after acute and subacute renal insults. Am J Pathol (2001) 1.05
Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1985) 1.04
Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med (1976) 1.04
Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science (1982) 1.04
Reversibility of gentamicin nephrotoxicity in rats: recovery during continuous drug administration. Proc Soc Exp Biol Med (1979) 1.04
Role of splenectomy in renal transplantation. Urology (1973) 1.04
Drug dosing guidelines in patients with renal failure. West J Med (1992) 1.03
Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int (1987) 1.03
The hemolytic-uremic syndrome in nonrelated adopted siblings. J Pediatr (1969) 1.03
Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother (1988) 1.03
Intravenous immune globulin therapy in hypogammaglobulinemia. A review. Am J Med (1984) 1.03
Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis (1995) 1.02
Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents. Ann Intern Med (1980) 1.02
Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis. Oncogene (2006) 1.02
Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01
A guide to drug therapy in renal failure. JAMA (1974) 1.01
Cyclosporine-induced acute renal dysfunction in the rat. Evidence of arteriolar vasoconstriction with preservation of tubular function. Transplantation (1987) 1.01
Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity. Antimicrob Agents Chemother (1991) 1.00
Ethylene glycol intoxication. Prevention of renal failure by aggressive management. JAMA (1973) 1.00
Macroscopic hematuria in mesangial IgA nephropathy: correlation with glomerular crescents and renal dysfunction. Kidney Int (1983) 1.00
Induction of contraction in isolated rat aorta by cyclosporine. Transplantation (1987) 1.00
Postrenal transplant erythrocytosis: a review of 53 patients. Kidney Int (1983) 0.99
Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states. Am J Med (1984) 0.99
Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens (1998) 0.99
Antilymphocyte antisera in immunologically mediated renal disease. JAMA (1969) 0.99
Clinical aspects of autoimmune hemolytic anemia. Semin Hematol (1976) 0.98
Addisonian pernicious anemia with positive antiglobulin tests. A multiple autoimmune disease syndrome. Am J Clin Pathol (1968) 0.98
Chronic effects of focused electrohydraulic shock waves on renal function and hypertension. J Urol (1991) 0.98
Synthesis of peptide analogues using the multipin peptide synthesis method. Anal Biochem (1991) 0.98
Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int (1995) 0.98
Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J Infect Dis (1982) 0.97
Amino-terminal sequence of a large form of basic fibroblast growth factor isolated from human benign prostatic hyperplastic tissue. Biochem Biophys Res Commun (1987) 0.97
Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis (1994) 0.97
Clinical characteristics and diagnostic considerations in acquired renal cystic disease. Kidney Int (1986) 0.97
Cyclosporine-associated hypertension. Am J Med (1988) 0.97
Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. Kidney Int (1999) 0.97
SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int (1996) 0.97
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int (1998) 0.96
Analgesic nephropathy--a preventable renal disease. N Engl J Med (1989) 0.96
A practical guide to drug usage in adult patients with impaired renal function. JAMA (1970) 0.96
Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int (1996) 0.96
Home-based immunoglobulin infusion therapy: quality of life and patient health perceptions. Ann Allergy (1991) 0.95
Herpes simplex type 1 hepatitis in renal transplantation. Arch Intern Med (1980) 0.95
Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int (1996) 0.95
Reduction of experimental gentamicin nephrotoxicity in rats by dietary calcium loading. Antimicrob Agents Chemother (1982) 0.95
Autoimmune hemolytic anemia and neoplasia of the reticuloendothelium. With a hypothesis concerning etiologic relationships. Ann Intern Med (1968) 0.95
Autoimmune hemolytic anemia and ulcerative colitis: a multisystem immunodeficiency disease? Int Arch Allergy Appl Immunol (1970) 0.95